Toll-like receptors mediate proliferation and survival of multiple myeloma cells

Leukemia
J BohnhorstA Sundan

Abstract

Multiple myeloma (MM) is an incurable B-cell malignancy characterized by accumulation of malignant plasma cells in bone marrow (BM) and recurrent or persistent infections. Toll-like receptors (TLRs) are essential in the host defense against infections and today 10 human TLRs (TLR1-TLR10) and one TLR-homolog (RP105) have been characterized. B cells express several TLRs (mainly TLR1, 6, 7, 9, 10 and RP105) and TLR-initiated responses in B cells include proliferation, anti-apoptosis effect and plasma cell (PC) differentiation. The present study was designed to analyze the role of TLRs in MM. We show that frequent expressions of TLRs were detected in cell lines from MM patients (minimum six TLRs in each). In comparison, only few TLRs (mainly TLR1 and or RP105) were found expressed in PCs from BM of healthy donors. In addition, TLR-specific ligands induce increased proliferation and survival of the MM cell lines, partially due to an autocrine interleukin-6 production. Importantly, we demonstrate that also PC from MM patients proliferates in response to TLR-specific ligands. In conclusion, TLR-ligands may contribute to increased growth and survival of MM cells in MM patients.

References

Jul 1, 1994·European Journal of Haematology·M BörsetE Helseth
Jun 1, 1996·The American Journal of Medicine·M M OkenJ M Bennett
May 19, 2000·Cell Biology International·K GadóA Falus
Jul 6, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·M HirschfeldJ J Weis
Jul 6, 2000·The Journal of Experimental Medicine·H OgataA Tarakhovsky
Mar 30, 2001·Cellular Immunology·G A BishopM A Tomai
Feb 28, 2002·Annual Review of Immunology·Arthur M Krieg
Apr 24, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Veit HornungGunther Hartmann
May 3, 2002·Blood·Anne-Tove BrenneHenrik Hjorth-Hansen
Aug 24, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jaeho JungYong Sung Choi
Nov 5, 2002·Trends in Pharmacological Sciences·Steffen Hering
Nov 26, 2002·Hematology·Kenneth C AndersonG David Roodman
Dec 14, 2002·Science·Nadia L BernasconiAntonio Lanzavecchia
Jan 16, 2003·Immunology Letters·Shizuo Akira, Hiroaki Hemmi
Jul 9, 2003·Immunological Reviews·Teru HideshimaKenneth C Anderson
Sep 11, 2003·The Lancet Oncology·Sonja SeidlJohannes Drach
Jan 7, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Moritz WagnerGunther Hartmann
Jan 20, 2004·The Journal of Biological Chemistry·Katalin KarikóDrew Weissman
Mar 17, 2004·Current Opinion in Immunology·Miriam Shapiro-Shelef, Kathryn Calame
Jun 5, 2004·Journal of Leukocyte Biology·Min-Fu Tsan, Baochong Gao
Dec 8, 2004·Journal of Leukocyte Biology·Bernd JahrsdörferGeorge J Weiner
Mar 5, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Bernd JahrsdorferGunther Hartmann
Mar 26, 2005·Immunological Reviews·Ian R RifkinAnn Marshak-Rothstein
Apr 6, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Philip R GreippJan Westin
Apr 16, 2005·European Journal of Immunology·Birgit ScheelSteve Pascolo
Apr 27, 2005·Nature Immunology·Senad DivanovicChristopher L Karp
May 12, 2005·Current Opinion in Immunology·Stanford L Peng

❮ Previous
Next ❯

Citations

Mar 28, 2007·Inflammatory Bowel Diseases·Arman RahmanMarie-Louise Hammarström
Jan 7, 2011·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Dov Zipori
Dec 5, 2008·Nature Reviews. Cancer·Seth Rakoff-Nahoum, Ruslan Medzhitov
Mar 8, 2007·Journal of the National Cancer Institute·George AstrakianakisHarvey Checkoway
Jul 9, 2008·Biochemistry. Biokhimii︠a︡·S Rakoff-Nahoum, R Medzhitov
May 4, 2007·The Journal of Clinical Investigation·Wan-Wan Lin, Michael Karin
Aug 17, 2011·Journal of Nucleic Acids·Esmerina Tili, Jean-Jacques Michaille
Dec 29, 2013·Clinical & Developmental Immunology·Saskia StierMichael Linnebacher
Sep 15, 2009·Environmental Health Perspectives·Jessica I Lundin, Harvey Checkoway
May 19, 2009·Cancer Immunology, Immunotherapy : CII·Evelien L J M SmitsViggo F I Van Tendeloo
Feb 28, 2008·Epidemiology·Karen J WernliHarvey Checkoway
Aug 13, 2009·Leukemia & Lymphoma·Marta MuzioFederico Caligaris-Cappio
Dec 15, 2015·Expert Review of Clinical Immunology·Laleh SharifiAsghar Aghamohammadi
Nov 14, 2015·British Journal of Haematology·Tina BagratuniEfstathios Kastritis
Sep 21, 2013·Critical Reviews in Oncology/hematology·Sara HarsiniNima Rezaei
Aug 13, 2014·Journal of Hematology & Oncology·Johana M Isaza-CorreaLydia Visser
Jun 12, 2012·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Pelin MutluUfuk Gündüz
May 26, 2012·Pharmacology & Therapeutics·M J Paul-ClarkJ A Mitchell
Jan 18, 2011·Critical Reviews in Oncology/hematology·Jahangir AbdiFrank Redegeld
Aug 24, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Martin GrimmMartin Gasser
Jul 3, 2010·Leukemia Research·David ChironCatherine Pellat-Deuceunynck
Mar 4, 2009·Current Problems in Cancer·S Vincent Rajkumar
May 23, 2014·Immunologic Research·Claire M Buchta, Gail A Bishop
Jan 14, 2010·Immunology·Isabelle Bekeredjian-Ding, Gaetan Jego
Aug 10, 2007·British Journal of Haematology·Guy PrattPaul Moss
Oct 12, 2013·European Journal of Haematology·Nishant TagejaOla Landgren
Dec 18, 2007·Biochemical and Biophysical Research Communications·Li WangXuetao Cao

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

B cell Differentiation

Depending on the signal received through the B cell receptor and other receptors, B cells differentiate into follicular or marginal zone B cells. Here is the latest research pertaining to this differentiation process.